연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
2487. PI3K alpha delta Inhibitor Combined With Radiation Enhances the Antitumor Immune Effect of Anti-PD1 in a Syngeneic Murine Triple-Negative Breast Cancer Model
Won Ick Chang, Min Guk Han, Mi Hyun Kang, Ji Min Park, Eric Eunshik Kim, Junhyung Bae, Soyeon Ahn, In Ah Kim
Int J Radiat Oncol Biol Phys. 2021 Jul 1;110(3):845-858
Link
2486. Hypofractionated versus conventional fractionated radiotherapy for breast cancer in patients with reconstructed breast: Toxicity analysis
Dong-Yun Kim, Eonju Park, Chan Yeong Heo, Ung Sik Jin , Eun Kyu Kim,
Wonshik Han, Kyung Hwan Shin, In Ah Kim
Breast. 2021 Feb;55:37-44.
Link
2485. Robotic Completion Thyroidectomy via the Bilateral Axillo-Breast
Approach.
JungHak Kwak 1, Su-Jin Kim 1 2 3 4, Zhen Xu 1, Keunchul Lee 5, Jong-Hyuk Ahn 1, Hyeong Won Yu 5, Young Jun Chai 6, June Young Choi 5, Kyu Eun Lee 1 2 3 4
J Clin Med. 2021 Apr
15;10(8):1707
Link
2484. Perioperative hemodynamic instability in pheochromocytoma and
sympathetic paraganglioma patients.
Jung Hee Kim # 1, Hyung-Chul Lee # 2, Su-Jin Kim 3 4 5 6, Soo Bin Yoon 2, Sung Hye Kong 1, Hyeong Won Yu 7, Young Jun Chai 8, June Young Choi 7, Kyu Eun Lee 9 10 11 12, Kwang-Woong Lee 9, Seung-Kee Min 9, Chan Soo Shin 1, Kyu Joo Park 9
Sci Rep. 2021 Sep
17;11(1):18574
Link
2483. Clinical and Molecular Characteristics of PRKACA L206R Mutant
Cortisol-Producing Adenomas in Korean Patients
Insoon Jang 1, Su-Jin Kim 2 3 4, Ra-Young Song 5, Kwangsoo Kim 1, Seongmin Choi 1, Jang-Seok Lee 1, Min-Kyeong Gwon 1, Moon Woo Seong 6, Kyu Eun Lee 2 3 4, Jung Hee Kim 7
Endocrinol Metab
(Seoul). 2021
Dec;36(6):1287-1297
Link
2482. Discovery of acquired molecular signature on immune checkpoint inhibitors in paired tumor tissues
Shin Hye Yoo # 1 2, Jihui Yun # 3 4, Bhumsuk Keam 5 6, Seung-Pyo Hong 3 4, Chan-Young Ock 1, Jaemoon Koh 7, Sehui Kim 7, Yoon Kyung Jeon 7, Kyeong Cheon Jung 7, Miso Kim 1, Tae Min Kim 1 8, Dong-Wan Kim 1 8, Jong-Il Kim 3 4 8 9, Dae Seog Heo 1 8 2
Cancer Immunol Immunother
. 2021 Jun;70(6):1755-1769.
Link
2481. Role of concurrent chemoradiation on locally advanced unresectable adenoid cystic carcinoma
Hyerim Ha 1 2, Bhumsuk Keam 1 3, Chan-Young Ock 1, Tae Min Kim 1 3, Jin Ho Kim 4, Eun-Jae Chung 5, Seong Keun Kwon 5, Soon-Hyun Ahn 5, Hong-Gyun Wu 4, Myung-Whun Sung 5, Dae Seog Heo 1 3
Korean J Intern Med
. 2021 Jan;36(1):175-181.
Link
2480. A phase I study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors
Bhumsuk Keam 1 2, Chan-Young Ock 1, Tae Min Kim 1 2, Do-Youn Oh 1 2, Won Ki Kang 3, Yeon Hee Park 3, Jeeyun Lee 3, Ji Hye Lee 4, Yoen Hee Ahn 4, Hyeon Ju Kim 4, Sook Kyung Chang 4, Jihyun Park 4, Ji Yea Choi 4, Yun Jeong Song 4, Young Suk Park 5
Invest New Drugs
. 2021 Dec;39(6):1624-1632.
Link
2479. Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma who Received Systemic Treatment
Changhee Park 1, Miso Kim 1 2, Yoonjin Kwak 3, Kyung Chul Moon 3, Se Hyun Kim 4, Bhumsuk Keam 1 2, Yu Jung Kim 4, Tae Min Kim 1 2, Dong-Wan Kim 1 2
Cancer Res Treat
. 2021 Oct;53(4):1195-1203.
Link
2478. A phase II study of brentuximab vedotin in patients with relapsed or refractory Epstein-Barr virus-positive and CD30-positive lymphomas
Miso Kim 1, Jeong-Ok Lee 2, Jiwon Koh 3, Tae Min Kim 4, Ji Yun Lee 2, Yoon Kyung Jeon 5, Bhumsuk Keam 1, Dong-Wan Kim 1, Jong Seok Lee 2, Dae Seog Heo 1
Haematologica
. 2021 Aug 1;106(8):2277-2280.
Link